Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets

Published:2021-06 Issue:6 Volume:24 Page:839-845
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Chapman Richard H.,Kumar Varun M.,Whittington Melanie D.,Pearson Steven D.

Funder

National Institute for Health Care Management

Commonwealth Fund

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference18 articles.

1. Estimating the clinical pipeline of cell and gene therapies and their potential economic impact on the US healthcare system;Quinn;Value Health,2019

2. How do we value a cure?;Husereau;Expert Rev Pharmacoecon Outcomes Res,2015

3. The Value of Innovation. Report by the Decision Support Unit;Claxton,2009

4. The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal;Hettle;Health Technol Assess,2017

5. Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products;Crabb,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B;Journal of Managed Care & Specialty Pharmacy;2024-08

2. Assessing the impact of single or short-term administration on a therapy’s cost-effectiveness: a hypothetical disease-agnostic model;Journal of Medical Economics;2023-04-23

3. Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal;Expert Review of Pharmacoeconomics & Outcomes Research;2023-04-19

4. Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the “Age of Cures” and Their Implications for Dynamic Efficiency;Value in Health;2023-03

5. Therapeutic Genome Editing;Collaborative Bioethics;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3